Schmidt R, Osten B
Z Gesamte Inn Med. 1986 Jun 1;41(11):309-13.
During the last years the haemodialysis treatment in chronic uraemia has been admirably developed and improved. At now as ever high expenditure for the chronic dialysis programme the capacity at our disposal must optimally be used. For this it is necessary to detoxicate the patients in relatively short times of treatment as effective as possible. But the increase of the efficacy of the haemodialysis is limited, which is revealed in the fact that the patient under the highly effective treatment shows complications such as decrease of blood pressure, muscle spasms, nausea and vomiting as well as headache. The clinical findings of the patient may further depend on the age, on the dialysis technique being at our disposal, on the composition of the dialysis solution, the biocompatibility of the dialysis membrane, the level of the retention values as well as on nutrition, training condition of the patient, psychic factors and others. The scientific efforts for optimization of the haemodialysis treatment have the aim to realize a haemodialysis treatment adapted individually to each patient, in order to treat the individual patient as effective as possible, however, without complications.
在过去几年中,慢性尿毒症的血液透析治疗得到了令人钦佩的发展和改进。鉴于目前慢性透析项目的高昂费用,我们必须尽可能优化可支配的治疗能力。为此,有必要在相对较短的治疗时间内尽可能有效地使患者解毒。但是血液透析疗效的提高是有限的,这体现在高效治疗下的患者会出现诸如血压下降、肌肉痉挛、恶心、呕吐以及头痛等并发症。患者的临床症状可能还取决于年龄、我们所采用的透析技术、透析液的成分、透析膜的生物相容性、潴留值水平以及营养状况、患者的训练情况、心理因素等。优化血液透析治疗的科学努力旨在实现针对每个患者的个性化血液透析治疗,以便尽可能有效地治疗个体患者,同时避免并发症。